Last edition
News about "Heart Failure Treatment"
Bayer Receives FDA Priority Review for Kerendia in Type 1 Diabetes-Related Kidney Disease
Bayer receives US Food and Drug Administration (FDA) Priority Review (PR) for supplemental approval of Kerendia to treat adults with Type 1 Diabetes (T1D) and Chronic Kidney Disease (CKD), potentially becoming the first Mineralocorticoid Receptor Antagonist (MRA) approved for this patient population.
Heart Failure Treatment | 22/05/2026 | By News Bureau
AstraZeneca Pharma India has launched K+ Connect, a nationwide initiative bringing together multidisciplinary experts from 33 healthcare centres to strengthen long-term hyperkalaemia management in patients with heart failure and chronic kidney disease.
Heart Failure Treatment | 14/05/2026 | By News Bureau
EBR Systems Secures FDA Approval for WiSE System to Treat Advanced Heart Failure
Unlike conventional CRT, the WiSE System is the first and only to deliver leadless left ventricular endocardial pacing (LVEP), that closely aligns with the heart's natural conduction pathway.
Heart Failure Treatment | 19/04/2025 | By Abha | 531
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy